Unbound MEDLINE

[Function of cannabinoids in heart failure].

Abstract

Cannabinoids, substances derived from Cannabis sativa, have been used by humans as therapeutic agents for thousands of years. They act through the cannabinoid CB(1), CB(2), vanilloid TRPV1, and the as yet undefined putative endothelial cannabinoid receptors. Intensive research on the influence of cannabinoids on the cardiovascular system has been conducted since the 1990s after the discovery that cannabinoids are involved in hypotension connected with septic, cardiogenic, and hemorrhagic shock. One cannot exclude the future possibility of using cannabinoids as new therapeutic agents in diseases of the cardiovascular system. In the present paper the mechanisms of cannabinoids on heart failure are described. In the acute phase of myocardial infarction, cannabinoids protect the endothelium of coronary vessels and decrease the heart's necrotic area and the risk of arrhythmia. Cannabinoids also act in the chronic phase of myocardial infarction in the process of the heart remodeling. However, the present knowledge of the effects of cannabinoids on the acute and chronic phases of myocardial infarction and the possibility of using these agents in cardiovascular disease therapy is still insufficient.

Links

  • FREE Publisher Full Text
  • Authors

    Rudź R, Baranowska U, Malinowska B

    Source

    Postȩpy higieny i medycyny doświadczalnej (Online) 62: 2008 pg 174-84

    MeSH

    Cannabinoids
    Endothelium, Vascular
    Heart Failure
    Humans
    Receptor, Cannabinoid, CB1
    Receptor, Cannabinoid, CB2
    Ventricular Remodeling

    Pub Type(s)

    English Abstract
    Journal Article
    Review

    Language

    pol

    PubMed ID

    18464680